Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease
Cierra N. Sharp, Mark A. Doll, Judit Megyesi, et al.
AJP Renal Physiology (2018) Vol. 315, Iss. 1, pp. F161-F172
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury
Sara J. Holditch, Carolyn N. Brown, Andrew M. Lombardi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3011-3011
Open Access | Times Cited: 302
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 241
Natural products: potential treatments for cisplatin-induced nephrotoxicity
Chunyan Fang, Dayong Lou, Liqin Zhou, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 12, pp. 1951-1969
Open Access | Times Cited: 240
Rodent models of AKI-CKD transition
Ying Fu, Chengyuan Tang, Juan Cai, et al.
AJP Renal Physiology (2018) Vol. 315, Iss. 4, pp. F1098-F1106
Open Access | Times Cited: 202
N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation
Caizhen Li, Na Xie, Li Y, et al.
Free Radical Biology and Medicine (2018) Vol. 130, pp. 512-527
Closed Access | Times Cited: 96
Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence
Caizhen Li, Yanting Shen, Liuwei Huang, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 89
Role of food-derived antioxidants against cisplatin induced-nephrotoxicity
Tania Gómez‐Sierra, Dianelena Eugenio-Pérez, Argelia Sánchez-Chinchillas, et al.
Food and Chemical Toxicology (2018) Vol. 120, pp. 230-242
Closed Access | Times Cited: 83
Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis
Sophia M. Sears, Leah J. Siskind
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 7, pp. 1559-1567
Open Access | Times Cited: 72
Experimental models of acute kidney injury for translational research
Neil A. Hukriede, Danielle E. Soranno, Veronika Sander, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 5, pp. 277-293
Closed Access | Times Cited: 60
Divergent effects of AKI to CKD models on inflammation and fibrosis
Laurence M. Black, Jeremie M. Lever, Amie Traylor, et al.
AJP Renal Physiology (2018) Vol. 315, Iss. 4, pp. F1107-F1118
Open Access | Times Cited: 76
Adenine-induced animal model of chronic kidney disease: current applications and future perspectives
Qiao Yang, Songya Su, Nan Luo, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 7
TGF-β1 induces ROS to activate ferroptosis via the ERK1/2-WISP1 pathway to promote the progression of renal tubular epithelial cell fibrosis
Yi Zhou, Fengwu Luan, Xiaonan Feng, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin
Lauren Thompson, Stacey M. Tuey, Pamela González, et al.
AAPS Open (2025) Vol. 11, Iss. 1
Open Access
Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis
Anna Menshikh, Lauren Scarfe, Rachel Delgado, et al.
AJP Renal Physiology (2019) Vol. 317, Iss. 5, pp. F1383-F1397
Open Access | Times Cited: 44
Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment
Qingsi Wu, Jiading Wang, Yuan-Fang Wang, et al.
Nano Research (2021) Vol. 15, Iss. 4, pp. 3556-3568
Open Access | Times Cited: 33
Kidney organoids: a pioneering model for kidney diseases
Murat Tekgüç, Ronald C. van Gaal, Sebastien G. M. Uzel, et al.
Translational research (2022) Vol. 250, pp. 1-17
Open Access | Times Cited: 26
Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity
Zhengwei Ma, Xiaoru Hu, Han‐Fei Ding, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 613-628
Open Access | Times Cited: 24
A comparative review of murine models of repeated low-dose cisplatin-induced chronic kidney disease
Hongwei Su, C.C. Qiu
Lab Animal (2025)
Closed Access
C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury
Sophia M. Sears, Cierra N. Sharp, Austin Krueger, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 4, pp. F674-F685
Open Access | Times Cited: 35
Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice
N. Yamashita, Kunihiro Nakai, Tomohiro Nakata, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
F4/80hi Resident Macrophages Contribute to Cisplatin-Induced Renal Fibrosis
Sophia M. Sears, Alexis A. Vega, Zimple Kurlawala, et al.
Kidney360 (2022) Vol. 3, Iss. 5, pp. 818-833
Open Access | Times Cited: 20
Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity
Andrew Orwick, Sophia M. Sears, Cierra N. Sharp, et al.
AJP Renal Physiology (2023) Vol. 324, Iss. 3, pp. F287-F300
Open Access | Times Cited: 11
Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury
Guy J. M. Cameron, Kelly M. Cautivo, Svenja Loering, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 30
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
Xiaoru Hu, Zhengwei Ma, Lu Wen, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5618-5618
Open Access | Times Cited: 25
Persistent Activation of Autophagy After Cisplatin Nephrotoxicity Promotes Renal Fibrosis and Chronic Kidney Disease
Ying Fu, Xiang Yu, Wenwen Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top